FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2985081618> ?p ?o ?g. }

• W2985081618 endingPage "12" @default.
• W2985081618 startingPage "11" @default.
• W2985081618 abstract "Triple drug combination has shown to be effective in controlling blood pressure (BP) with low rates of drug-related side effects. The present study was conducted to compare the efficacy and safety of a triple pill of telmisartan/amlodipine/hydrochlorothiazide (HCTZ) with a dual combination of telmisartan/HCTZ in treating hypertensive patients who did not respond to monotherapies.A total of 512 patients were randomized to receive either low-dose triple pill or the dual combination therapy. The primary endpoint was BP normalization after 8 weeks. The secondary endpoints were BP normalization at 4 weeks, changes in BP from baseline to Week 8, comparison of BP normalization between treatment groups, and difference in BP responder rates. The analysis was conducted on the intent-to-treat (ITT), modified intent-to-treat (mITT) and per protocol (PP) population.Statistically significant difference was noted between triple pill and telmi+HCTZ in the normalization of BP at Week 8 in the mITT (p=0.041) and PP (p=0. 038) populations. Also, a statistically significant improvement was observed in BP normalization in triple pill group compared with telmi+HCTZ group in ITT (p=0.022) and mITT (p=0.015) populations after 4 weeks. At Week 8, a significant reduction in BP was seen compared to the baseline in both the treatment groups. There was no statistically significant difference between the two treatment groups in BP normalization. Diastolic BP responder rates were significantly better for triple pill group in PP population (p=0.046).The triple pill was found to be effective in achieving early normalization of BP in hypertensive patients who did not respond to monotherapies." @default.
• W2985081618 created "2019-11-22" @default.
• W2985081618 creator A5002893934 @default.
• W2985081618 creator A5009739842 @default.
• W2985081618 creator A5014852978 @default.
• W2985081618 creator A5023320412 @default.
• W2985081618 creator A5037120682 @default.
• W2985081618 creator A5061593226 @default.
• W2985081618 creator A5077715309 @default.
• W2985081618 date "2018-12-01" @default.
• W2985081618 modified "2023-10-01" @default.
• W2985081618 title "A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential Hypertension." @default.
• W2985081618 cites W1675495432 @default.
• W2985081618 cites W1913120406 @default.
• W2985081618 cites W1984523857 @default.
• W2985081618 cites W1987286147 @default.
• W2985081618 cites W1990666923 @default.
• W2985081618 cites W2002491207 @default.
• W2985081618 cites W2011751169 @default.
• W2985081618 cites W2014964241 @default.
• W2985081618 cites W2051825791 @default.
• W2985081618 cites W2061445891 @default.
• W2985081618 cites W2097743098 @default.
• W2985081618 cites W2098856788 @default.
• W2985081618 cites W2106320466 @default.
• W2985081618 cites W2126125759 @default.
• W2985081618 cites W2131805587 @default.
• W2985081618 cites W2133416234 @default.
• W2985081618 cites W2318820900 @default.
• W2985081618 cites W2320791986 @default.
• W2985081618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31313548" @default.
• W2985081618 hasPublicationYear "2018" @default.
• W2985081618 type Work @default.
• W2985081618 sameAs 2985081618 @default.
• W2985081618 citedByCount "1" @default.
• W2985081618 countsByYear W29850816182020 @default.
• W2985081618 crossrefType "journal-article" @default.
• W2985081618 hasAuthorship W2985081618A5002893934 @default.
• W2985081618 hasAuthorship W2985081618A5009739842 @default.
• W2985081618 hasAuthorship W2985081618A5014852978 @default.
• W2985081618 hasAuthorship W2985081618A5023320412 @default.
• W2985081618 hasAuthorship W2985081618A5037120682 @default.
• W2985081618 hasAuthorship W2985081618A5061593226 @default.
• W2985081618 hasAuthorship W2985081618A5077715309 @default.
• W2985081618 hasConcept C126322002 @default.
• W2985081618 hasConcept C126894567 @default.
• W2985081618 hasConcept C168563851 @default.
• W2985081618 hasConcept C197934379 @default.
• W2985081618 hasConcept C203092338 @default.
• W2985081618 hasConcept C2778375690 @default.
• W2985081618 hasConcept C2779646130 @default.
• W2985081618 hasConcept C2779716603 @default.
• W2985081618 hasConcept C2780361556 @default.
• W2985081618 hasConcept C2908647359 @default.
• W2985081618 hasConcept C71924100 @default.
• W2985081618 hasConcept C81603835 @default.
• W2985081618 hasConcept C84393581 @default.
• W2985081618 hasConcept C98274493 @default.
• W2985081618 hasConcept C99454951 @default.
• W2985081618 hasConceptScore W2985081618C126322002 @default.
• W2985081618 hasConceptScore W2985081618C126894567 @default.
• W2985081618 hasConceptScore W2985081618C168563851 @default.
• W2985081618 hasConceptScore W2985081618C197934379 @default.
• W2985081618 hasConceptScore W2985081618C203092338 @default.
• W2985081618 hasConceptScore W2985081618C2778375690 @default.
• W2985081618 hasConceptScore W2985081618C2779646130 @default.
• W2985081618 hasConceptScore W2985081618C2779716603 @default.
• W2985081618 hasConceptScore W2985081618C2780361556 @default.
• W2985081618 hasConceptScore W2985081618C2908647359 @default.
• W2985081618 hasConceptScore W2985081618C71924100 @default.
• W2985081618 hasConceptScore W2985081618C81603835 @default.
• W2985081618 hasConceptScore W2985081618C84393581 @default.
• W2985081618 hasConceptScore W2985081618C98274493 @default.
• W2985081618 hasConceptScore W2985081618C99454951 @default.
• W2985081618 hasIssue "12" @default.
• W2985081618 hasLocation W29850816181 @default.
• W2985081618 hasOpenAccess W2985081618 @default.
• W2985081618 hasPrimaryLocation W29850816181 @default.
• W2985081618 hasRelatedWork W1598142205 @default.
• W2985081618 hasRelatedWork W1614568348 @default.
• W2985081618 hasRelatedWork W1931387313 @default.
• W2985081618 hasRelatedWork W1966648594 @default.
• W2985081618 hasRelatedWork W1972949333 @default.
• W2985081618 hasRelatedWork W1978884506 @default.
• W2985081618 hasRelatedWork W2006478907 @default.
• W2985081618 hasRelatedWork W2063790407 @default.
• W2985081618 hasRelatedWork W2086338296 @default.
• W2985081618 hasRelatedWork W2095126915 @default.
• W2985081618 hasRelatedWork W2133906755 @default.
• W2985081618 hasRelatedWork W2138008488 @default.
• W2985081618 hasRelatedWork W2166773361 @default.
• W2985081618 hasRelatedWork W2257778314 @default.
• W2985081618 hasRelatedWork W2315320731 @default.
• W2985081618 hasRelatedWork W2423845659 @default.
• W2985081618 hasRelatedWork W2586222154 @default.
• W2985081618 hasRelatedWork W2767740630 @default.
• W2985081618 hasRelatedWork W2884584241 @default.
• W2985081618 hasRelatedWork W2182820568 @default.

• next